Bravo Confirms Water is Top Priority in Ebola Outbreak


NEW YORK, Aug. 27, 2014 (GLOBE NEWSWIRE) -- Bravo Enterprises Ltd. (OTCQB:OGNG) reports that in the effort to contain the spread of Ebola in Liberia's capital Monrovia, tens of thousands of people have been barricaded. While the Ebola disease is a real danger, the lack of food and water available to the people is equally as troubling.

The price of water has quadrupled in a matter of days in places with no running water and humid temperatures in Monrovia. Located on a peninsula, Bravo's air to water machines would be of great assistance in this desperate situation.

Bravo's selection of commercial and industrial machines can be a temporary and permanent alternative water supply for Liberia and countries like it. This is especially true given the humid temperature in those regions, whereby Bravo's machines can convert the moisture in the air to much needed drinking water.

"The Company is working with its Costa Rican Distributor for sale of the large machines because of arsenic found in the well water there," states Jaclyn Cruz, President of Bravo, "we look forward to assisting in any way we can with parties interested in using Bravo's atmospheric machines to generate clear drinking water in all regions of the world who need it."

About Bravo Enterprises Ltd.

Bravo is a manufacturer and distributor of atmospheric water harvesting machines for the production of clean, safe drinking water for human consumption.

For further information contact: 1-888-488-6882

Visit our website: www.bravoenterprises.ws or www.splashwaterforlife.com

/s/ Jaclyn Cruz               

Jaclyn Cruz, Director              

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical fact are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays in testing and evaluation of products and other risks detailed from time to time in Bravo Enterprises Ltd.'s filings with the SEC.